During the past decade, Manchester Clinical Research Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Manchester Clinical Research Centre" are "Dyslipidemia" (2 trials), "Huntington's Disease" (2 trials), "Hypercholesterolemia" (2 trials), "Dyslipidemias" (1 trials) and "Hypercholesterolemia or Combined Dyslipidemia" (1 trials). Many other conditions were trialed in "Manchester Clinical Research Centre" in a lesser frequency.

Most popular intervention types in "Manchester Clinical Research Centre" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (4 trials), "20 mg BID of PF-02545920" (1 trials), "Atorvastatin" (1 trials), "PF-02545920" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Manchester Clinical Research Centre" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Manchester Clinical Research Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Manchester Clinical Research Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Manchester Clinical Research Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".